» Articles » PMID: 26276768

Acute Leukemias of Ambiguous Origin

Overview
Specialty Pathology
Date 2015 Aug 16
PMID 26276768
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This session of the Society for Hematopathology/European Association for Haematopathology Workshop focused on acute leukemias of ambiguous origin.

Methods: We provide an overview of mixed-phenotype acute leukemia (MPAL) as recognized in the current World Health Organization classification and summarize diagnostic criteria for major categories of MPAL: B/myeloid, T/myeloid, B/T, and B/T/myeloid.

Results: Most MPAL cases submitted were B/myeloid and T/myeloid MPAL, the most frequent types, but three cases of B/T MPAL were also submitted, and examples of all categories are illustrated. We emphasize that a comprehensive approach to immunophenotyping is required to accurately establish the diagnosis of MPAL. Flow cytometry immunophenotyping using a large panel of antibodies is needed as well as confirmatory immunohistochemical analysis and cytochemistry studies for myeloperoxidase and nonspecific esterase. We discuss technical issues in determining blast lineage and possible pitfalls in MPAL diagnosis. In particular, rare cases of B-acute lymphoblastic leukemia (B-ALL) can express myeloperoxidase but are otherwise consistent with B-ALL and should be treated as such. Last, we review the differential diagnosis between acute undifferentiated leukemia and acute myeloid leukemia with minimal differentiation.

Conclusions: There was an agreement that diagnosis of MPAL can be challenging, especially if applied flow cytometry panels are not comprehensive enough.

Citing Articles

How to think about acute leukemia of ambiguous lineage.

Weinberg O Hematology Am Soc Hematol Educ Program. 2024; 2024(1):287-292.

PMID: 39644014 PMC: 11665627. DOI: 10.1182/hematology.2024000554.


Recognizing Minor Leukemic Populations with Monocytic Features in Mixed-Phenotype Acute Leukemia by Flow Cell Sorting Followed by Cytogenetic and Molecular Studies: Report of Five Exemplary Cases.

Semchenkova A, Zerkalenkova E, Demina I, Kashpor S, Volchkov E, Zakharova E Int J Mol Sci. 2023; 24(6).

PMID: 36982331 PMC: 10049081. DOI: 10.3390/ijms24065260.


Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic Strategies.

George B, Yohannan B, Gonzalez A, Rios A Biomedicines. 2022; 10(8).

PMID: 36009521 PMC: 9405901. DOI: 10.3390/biomedicines10081974.


The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia.

Lopez-Millan B, Costales P, Gutierrez-Aguera F, de la Guardia R, Roca-Ho H, Vinyoles M Cancers (Basel). 2022; 14(6).

PMID: 35326743 PMC: 8946166. DOI: 10.3390/cancers14061593.


Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies.

Sin C, Man P Front Oncol. 2021; 11:750789.

PMID: 34912707 PMC: 8666570. DOI: 10.3389/fonc.2021.750789.